U.S. pharma big copyright scrapped two experimental weight loss pills previous 12 months—a once-each day tablet, lotiglipron, as a result of elevated liver enzymes in addition to a two times-daily capsule, danuglipron, due to strong side effects—but CEO Albert Bourla has said the company is determined to “Perform and earn” from the weight p